Skip to main content
OpenTrials

Clinical trial condition

Urinary Bladder Neoplasms

Explore clinical trials studying Urinary Bladder Neoplasms. Study availability and eligibility vary by location and protocol.

1,200 public trials 264 recruiting studies
Refine in advanced search Browse all conditions

Urinary Bladder Neoplasms trial results

Recruiting

Pembrolizumab and EV With Radiation Therapy for MIBC Patients (PEVRAD)

NCT05879653

Conditions
Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations
  • Kobe City Medical Center General Hospital Kobe, Hyōgo, Japan
  • University of Tsukuba Hospital Tsukuba, Ibaraki, Japan
  • Kyoto University Hospital Kyoto, Japan
  • Osaka Metropolitan University Hospital Osaka, Japan
View Trial Details
Recruiting

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

NCT05059444

Conditions
Adenocarcinoma, Adnexal Diseases, Bladder Carcinoma, +79 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Ironwood Cancer & Research Centers Chandler, Arizona, United States
  • Genesis Cancer Center Hot Springs, Arkansas, United States
  • University of California, San Diego La Jolla, California, United States
View all 57 locations
View Trial Details
Recruiting

Bladder Fiducial Markers and Multiparametric-MRI (Mp-MRI) to Optimize Bladder Chemo-radiotherapy

NCT04442724

Conditions
Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +10 more
Locations
  • Cedars-Sinai Medical Center (CSMC) Los Angeles, California, United States
  • University of California Los Angeles Los Angeles, California, United States
  • Harvard School of Medicine/Massachusetts General Hospital (MGH) Boston, Massachusetts, United States
View Trial Details
Recruiting

Prospective Bladder Cancer Infrastructure (ProBCI)

NCT04503577

Conditions
Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations
  • Jeroen Bosch Hospital 's-Hertogenbosch, Netherlands
  • ZGT Almelo, Netherlands
  • Meander Medical Center Amersfoort, Netherlands
  • Amsterdam UMC, location VUMC Amsterdam, Netherlands
View all 23 locations
View Trial Details
Recruiting

Clinical Trail of Neoadjuvant of Tislelizumab Combined With Palbociclib in Patients With Platinum-refractory Bladder Urothelial Carcinoma

NCT06364956

Conditions
Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations
  • Nanfang Hospital, Southern Medical University Guangzhou, Guangdong, China
  • Sun Yat-sen Memorial Hospital Guangzhou, Guangdong, China
  • The First Affiliated Hospital of Sun Yat-sen University Guangzhou, Guangdong, China
  • The Third Affiliated Hospital of Sun Yat-sen University Guangzhou, Guangdong, China
View Trial Details

Related conditions